Gadolinium-based ultra-small nanoparticles augment radiotherapy-induced T-cell response to synergize with checkpoint blockade immunotherapy.
Song H, Sun H, He N, Xu C, Wang Y, Du L, Liu Y, Wang Q, Ji K, Wang J, Zhang M, Gu Y, Zhang Y, Feng L, Tillement O, Wang W, Liu Q.
Song H, et al. Among authors: wang w, wang j, wang y, wang q.
Nanoscale. 2022 Aug 11;14(31):11429-11442. doi: 10.1039/d2nr02620a.
Nanoscale. 2022.
PMID: 35904053